(Q48626345)

13 February 2018

title

Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors. (English)

1 reference

13 February 2018

author name string

Terry Lichtor

1

1 reference

13 February 2018

Roberta P Glick

2

1 reference

13 February 2018

Katherine Tarlock

3

1 reference

13 February 2018

Shannon Moffett

4

1 reference

13 February 2018

Elizabeth Mouw

5

1 reference

13 February 2018

Edward P Cohen

6

1 reference

13 February 2018

publication date

1 May 2002

1 reference

13 February 2018

published in

Cancer Gene Therapy

1 reference

13 February 2018

volume

9

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

464-469

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700459

exact match

0 references

cites work

Cytokines: structure, function and synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

Lymphokines and cytokines as cancer treatment. Immunotherapy realized

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

A new dominant hybrid selective marker for higher eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

Development of a new mouse brain tumor model using implantable micro-cannulas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

7 January 2021

Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

7 January 2021

Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

7 January 2021

Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700459

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700459

1 reference

13 February 2018

PubMed ID

11961669

1 reference

13 February 2018